Formisano, Luigi
Lu, Yao
Servetto, Alberto
Hanker, Ariella B. http://orcid.org/0000-0002-8655-8341
Jansen, Valerie M.
Bauer, Joshua A.
Sudhan, Dhivya R.
Guerrero-Zotano, Angel L. http://orcid.org/0000-0003-0318-9120
Croessmann, Sarah
Guo, Yan
Ericsson, Paula Gonzalez http://orcid.org/0000-0002-6292-6963
Lee, Kyung-min
Nixon, Mellissa J.
Schwarz, Luis J.
Sanders, Melinda E.
Dugger, Teresa C.
Cruz, Marcelo Rocha
Behdad, Amir
Cristofanilli, Massimo
Bardia, Aditya
O’Shaughnessy, Joyce
Nagy, Rebecca J.
Lanman, Richard B. http://orcid.org/0000-0001-8122-4329
Solovieff, Nadia
He, Wei
Miller, Michelle
Su, Fei
Shyr, Yu
Mayer, Ingrid A.
Balko, Justin M. http://orcid.org/0000-0002-4263-5974
Arteaga, Carlos L.
Article History
Received: 2 July 2018
Accepted: 14 February 2019
First Online: 26 March 2019
Competing interests
: C.L.A. receives grant support from Pfizer, Lilly, Bayer, and Radius. He serves in advisory roles to Symphogen, Daiichi Sankyo, TAIHO Oncology, Novartis, Merck, PUMA Biotechnology, Lilly, Radius, Sanofi, OrigiMed, and H3Biomedicine. He serves in the Scientific Advisory Board of the Komen Foundation. He holds stock options in Provista and Y-TRAP. R.J.N and R.B.L. are employees of Guardant Health; N.S., M.M., and F.S. are employees of Novartis Pharmaceuticals Corporation. The remaining authors declare no competing interests.